- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02688283
The Effect on Glycemic Responses and Subjective Ratings of Satiety of a Snack With or Without Ingredients to Slow Carbohydrate Digestion
September 25, 2018 updated by: PepsiCo Global R&D
Randomized, Controlled, Cross-over Study Comparing The Effect on Glycemic Responses and Subjective Ratings of Satiety of a Snack With or Without Ingredients to Slow Carbohydrate Digestion
The objective of this trial is to compare a snack with ingredients (whole grains and dietary fiber) to slow carbohydrate digestion to a similar control snack without such ingredients and evaluate the effect of the snack on glycemic response and subjective satiety.
The test product will be compared with a control product as well as white bread in a randomized, controlled, crossover trial including 20 healthy males or females between the ages of 18 and 70 and having a body mass index (BMI) between 25 and 30 kg/m2.
Following an overnight fast, participants will be given each of the study products in a random order at least a week apart.
Glucose and insulin will be measured before product consumption and over a period of four hours.
Visual analog scales to measure subjective satiety will also be administered over a period of four hours.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy males or females between the ages of 18 and 70 inclusive
- No chronic medications other than oral contraceptives
- Body Mass Index (BMI) between 25 and 30 kg/m2 inclusive.
- Body weight stable in a 5 kg range in the 3 months prior to study entry
Exclusion Criteria:
- Pregnant or nursing a baby
- Women with child-bearing potential who are unwilling to use an effective means of contraception during the study which could include abstinence.
- Adults unable to consent and prisoners
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test-cluster
56g of optimized savory cluster made through a proprietary process with slowly digestible carbohydrates and fiber
|
Test cluster is an optimized savory cluster made through a proprietary baking process combined with slow digestible carbohydrates and fiber
|
|
Placebo Comparator: Control-cluster
56g of control cluster made from general baking process with typical ingredients commonly used in commercially available energy snacks or bars
|
Test cluster is an optimized savory cluster made through a proprietary baking process combined with slow digestible carbohydrates and fiber
|
|
Placebo Comparator: White-bread
45g of white bread containing equivalent amount of available carbohydrate in 56g of optimized savory cluster
|
Test cluster is an optimized savory cluster made through a proprietary baking process combined with slow digestible carbohydrates and fiber
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
area under the curve (AUC) for glucose and insulin
Time Frame: 0-4 hours post consumption
|
0-4 hours post consumption
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
AUC for the visual analog scale (VAS) ratings of satiety
Time Frame: 0-4 hours post consumption
|
0-4 hours post consumption
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Frank Greenway, MD, Pennington Biomedical Research Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2015
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
April 1, 2016
Study Registration Dates
First Submitted
February 17, 2016
First Submitted That Met QC Criteria
February 17, 2016
First Posted (Estimate)
February 23, 2016
Study Record Updates
Last Update Posted (Actual)
September 27, 2018
Last Update Submitted That Met QC Criteria
September 25, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- PEP-1512
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glycemic Response; Satiety
-
Clinical Nutrition Research Centre, SingaporeCompleted
-
King Faisal UniversitySaudi Food and Drug AuthorityRecruitingDietary Intervention | Glycemic Response; Satiety | Postprandial Glucose | Fasting, Time RestrictedSaudi Arabia
-
Loma Linda UniversityHass Avocado BoardCompletedGlycemic Index | Insulin | Satiety | Gastrointestinal Peptides and HormonesUnited States
-
University of TorontoAlliance for Potato Research and EducationRecruitingObesity | Diabetes | Appetite Regulation | Glycemic Control | Satiety ResponseCanada
-
Mondelēz International, Inc.Reading Scientific Services Ltd.Completed
-
University of ReadingPepsiCo Global R&DCompleted
-
Nutricia ResearchCompletedGlycemic ResponseCanada
-
Glycemic Index Laboratories, IncUniversity of Guelph; Guelph Research and Development Centre, Agriculture and...Completed
-
Purdue UniversityPepsiCo Global R&DCompletedGlycemic Response
Clinical Trials on Nutrient cluster
-
Harvard Pilgrim Health CareDuke University; Brigham and Women's Hospital; University of California, San... and other collaboratorsCompleted
-
International Centre for Diarrhoeal Disease Research...Completed
-
University of Illinois at Urbana-ChampaignCompletedHealthyUnited States
-
University of North Carolina, Chapel HillThe Bloomberg Family Foundation, Inc.CompletedDietary ExposureUnited States
-
Duke UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedSurgical Site Infection | Infection ControlUnited States
-
PepsiCo Global R&DCompletedPeak Rise of Blood Glucose
-
Azienda Ospedaliero, Universitaria PisanaUnknown
-
Tampere UniversityUniversity of California, Davis; Bill and Melinda Gates Foundation; Kamuzu University...Completed
-
Icahn School of Medicine at Mount SinaiCompleted